AIM vs AMGN: Which Stock is Better?
Side-by-side comparison of Aim Immunotech Inc and Amgen Inc in 2026
AIM
Aim Immunotech Inc
$0.69
AMGN
Amgen Inc
$379.27
Key Metrics Comparison
| Metric | AIM | AMGN | Winner |
|---|---|---|---|
| Market Cap | $2.79M | $203.23B | AMGN |
| P/E Ratio | N/A | 26.53 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | -0.3% | 0.1% | AMGN |
| Gross Margin | 15.2% | 70.8% | AMGN |
Analyze AIM
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AIM or AMGN a better investment?
Comparing AIM and AMGN: Aim Immunotech Inc has a market cap of $2.79M while Amgen Inc has $203.23B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AIM and AMGN?
AIM (Aim Immunotech Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AIM or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AIM or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.3% for AIM.
Which company is more profitable: AIM or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 15.2% for AIM.
Which is the larger company: AIM or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $203.23B compared to $2.79M for AIM.
Should I buy AIM or AMGN in 2026?
Both AIM and AMGN have investment merit. AIM trades at $0.69 while AMGN trades at $379.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AIM and AMGN stock?
Key differences: Market Cap ($2.79M vs $203.23B), P/E Ratio (N/A vs 26.5x), Revenue Growth (-0.3% vs 0.1%), Gross Margin (15.2% vs 70.8%).